Hansoh Pharmaceutical Group Co Ltd - Research and Development

Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Research-and-Development" stands at 2.86 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 32.96 percent compared to the value the year prior.
The 1 year change in percent is 32.96.
The 3 year change in percent is 54.45.
The 5 year change in percent is 203.66.

The Serie's long term average value is 1.43 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 99.48 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +540.10%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.